Ms. Cathryn Bennett is a highly regarded leader with a proven record of accomplishment in managing clinical operations and clinical teams for global clinical trials from Phase 1 through Phase 4, with budgets ranging from 5 million to 25 million dollars per study. She has a broad knowledge of FDA and international regulatory approval and processes. Ms. Bennett’s experience includes facilitating a successful type 2 diabetes (T2DM) drug development program, which resulted in a 75 million dollar partner investment. She has authored articles related to diabetes, hemophilia, and sarcoma.
Prior to joining HighTide, Ms. Bennett served as Senior Director Clinical Operations for Conatus Pharmaceuticals. Her other clinical operations experience includes Director Clinical Operations, Ansun Biopharma; Director Clinical Operations, MabVax Therapeutics; and Associate Director Clinical Operations, Phenomix Corporation. Prior to managing clinical operations for drug development sponsors, Ms. Bennett held various clinical operations roles at clinical research organizations, including Connaught Laboratories and Cato Research.
Ms. Bennett received a BN in nursing from University of Calgary and an Associate Degree in Science from Mount Royal College.
© 2023 HighTide Therapeutics Inc.